Citation Impact
Citing Papers
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
2007
Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease
2011
Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension
2013
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Blocking Macrophage Leukotriene B 4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
2013
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells
2017
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
2020 Standout
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience
2020
Shared and distinct mechanisms of fibrosis
2019
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
2014 Standout
Sarcopenia: a chronic complication of type 2 diabetes mellitus
2018 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Bone morphogenetic protein receptors and signal transduction
2009 Standout
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
Hallmarks of aging: An expanding universe
2023 Standout
A global view of pulmonary hypertension
2016 Standout
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease
2017
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
The expanding universe of hypoxia
2008 StandoutNobel
Vascular Cells in Blood Vessel Wall Development and Disease
2016
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension
2012
BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH
2012
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
2017
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
2007
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
2009
Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
2019
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
2014 Nobel
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
2013
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
2018
Major lung complications of systemic sclerosis
2018
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
2017
Mechanisms of disease: pulmonary arterial hypertension
2011
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
2020
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Cellular senescence: from physiology to pathology
2014 Standout
The Crossroads of Iron with Hypoxia and Cellular Metabolism. Implications in the Pathobiology of Pulmonary Hypertension
2014
BMP4 Increases Canonical Transient Receptor Potential Protein Expression by Activating p38 MAPK and ERK1/2 Signaling Pathways in Pulmonary Arterial Smooth Muscle Cells
2013
Targeting Energetic Metabolism
2011
Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension
2007
Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization
2012
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Pulmonary Hypertension Secondary to COPD
2012
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
The Fibroblast Growth Factor signaling pathway
2015 Standout
Life without Peripheral Serotonin: Insights from Tryptophan Hydroxylase 1 Knockout Mice Reveal the Existence of Paracrine/Autocrine Serotonergic Networks
2012
Macrophage Polarization
2016 Standout
The role of chemokines and chemokine receptors in pulmonary arterial hypertension
2019
Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension
2008
Aging, Cellular Senescence, and Cancer
2012 Standout
Plasma C-Reactive Protein and Endothelin-1 Level in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
2010
Pulmonary Arterial Hypertension
2006
Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
2015
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
2014
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling
2014
FGF signaling is required for anterior but not posterior specification of the murine liver bud
2014
Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
2022
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
2017
Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation
2007
Adventitial Fibroblasts Induce a Distinct Proinflammatory/Profibrotic Macrophage Phenotype in Pulmonary Hypertension
2014
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
2014
Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary Hypertension
2011
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Fibroblast growth factor receptor 1 is a key inhibitor of TGFβ signaling in the endothelium
2014
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Endothelial Cell Biology
2010
Works of Ly Tu being referenced
Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension
2007
Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
2010
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents
2009
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
2013
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension
2012
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis
2018
New Molecular Targets of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
2015
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
2009
Bone morphogenetic protein signalling in heritableversusidiopathic pulmonary hypertension
2009
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
2009
RhoA and Rho Kinase Activation in Human Pulmonary Hypertension
2009
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
2017
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
2012
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
2015
A Critical Role for p130 Cas in the Progression of Pulmonary Hypertension in Humans and Rodents
2012
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
2016
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
2017
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension
2019
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
2018
Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension
2014
Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension
2006
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension
2020
Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension
2014
Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22α‐targeted overexpression of the serotonin transporter
2009